Genetic testing for personalized treatment of endometrial cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study uses advanced genetic testing (next-generation sequencing) to look at the molecular makeup of endometrial cancer or its rare subtype, carcinosarcoma. The goal is to better understand the cancer and possibly guide more personalized treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with endometrial cancer or carcinosarcoma (a rare subtype).
- Your diagnosis and treatment (with or without surgery) happened in the last 5 years.
- You did not receive chemotherapy before surgery.
- A stored tumor sample (formalin-fixed paraffin block) of at least 1 cm³ is available from your cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This trial studies tumor DNA in blood and tissue from people with aggressive endometrial cancer to better understand the disease. You donate samples during surgery and follow-up visits.
This study tests if personalized treatment plans, based on detailed genetic testing of your tumor, can help women with recurrent ovarian, cervical, or endometrial cancer. You will work with a team of specialists to find the best options for you.
This study looks at whether knowing the genetic profile (molecular classification) of your endometrial cancer can help guide fertility-sparing treatment. It aims to improve outcomes for young patients who want to preserve their ability to have children.
This trial tests whether a blood test for ctDNA (cancer DNA fragments) can help doctors decide if standard chemotherapy plus an immunotherapy drug is working for people with advanced or recurrent endometrial cancer. It may help tailor your treatment based on how the cancer responds.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
Hear when a new Endometrial Cancer, Endometrial Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.